Cargando…
Neuropeptide Y receptors: a promising target for cancer imaging and therapy
Neuropeptide Y (NPY) was first identified from porcine brain in 1982, and plays its biological functions in humans through NPY receptors (Y(1), Y(2), Y(4) and Y(5)). NPY receptors are known to mediate various physiological functions and involve in a majority of human diseases, such as obesity, hyper...
Autores principales: | Li, Juan, Tian, Yuchen, Wu, Aiguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669009/ https://www.ncbi.nlm.nih.gov/pubmed/26816643 http://dx.doi.org/10.1093/rb/rbv013 |
Ejemplares similares
-
Neuropeptide Y and its Y2 Receptor – Potential Targets in Neuroblastoma Therapy
por: Lu, Congyi, et al.
Publicado: (2010) -
Finding promising cures for migraine: targeting neuropeptides
Publicado: (2021) -
Therapeutic potential of neuropeptide Y (NPY) receptor ligands
por: Brothers, Shaun P, et al.
Publicado: (2010) -
Neuropeptide S Receptor as an Innovative Therapeutic Target for Parkinson Disease
por: Holanda, Victor A. D., et al.
Publicado: (2021) -
PET Imaging of the Neuropeptide Y System: A Systematic Review
por: Fonseca, Inês C. F., et al.
Publicado: (2022)